A cutting-edge artificial intelligence supercomputer will support cancer vaccine research at Oxford University, offering new hope for faster, more precise discoveries.
The research team has secured 10,000 hours on the powerful Dawn machine to analyse extensive cancer patient data.
The team at the Nuffield Department of Medicine at the University of Oxford has been granted access to one of the country’s most advanced AI supercomputers as part of a government-funded program. Known as Dawn, this state-of-the-art system will enable scientists to sift through tens of thousands of datasets with unprecedented speed and accuracy.
Dr Lennard Lee, who heads this endeavour, describes the project as a “science fiction moment come to life”. He explains that the complexity of cancer presents a formidable challenge, but the computational power available now allows them to reveal hidden patterns that were previously impossible to detect.
This platform gives us a unique opportunity to accelerate vaccine design by processing vast amounts of information quickly and at scale – Dr Lee, said
He is an associate professor at Oxford’s Centre for Immuno-Oncology and leads this forward-looking campaign.
The research effort will also contribute to the Oxford Neoantigen Atlas, a publicly accessible online resource aimed at supporting vaccine development programs throughout the UK. Researchers hope their work will lay the groundwork for new vaccines that were once thought unattainable.
Leave a comment